Gastrointestinal Bleeding: Presentation, Differential Diagnosis and Epidemiology

[1]  V. Wong,et al.  Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding , 2010, Annals of Internal Medicine.

[2]  J. Sung,et al.  Causes of Mortality in Patients With Peptic Ulcer Bleeding: A Prospective Cohort Study of 10,428 Cases , 2010, The American Journal of Gastroenterology.

[3]  Á. Lanas,et al.  Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice , 2009, The American Journal of Gastroenterology.

[4]  Á. Lanas,et al.  Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. , 2009, Gastroenterology clinics of North America.

[5]  E. Kuipers,et al.  Systematic review: the global incidence and prevalence of peptic ulcer disease , 2009, Alimentary pharmacology & therapeutics.

[6]  A. Ananthakrishnan,et al.  Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  V. Wong,et al.  Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  G. Kaplan,et al.  Weekend versus weekday admission and mortality from gastrointestinal hemorrhage caused by peptic ulcer disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  A. Sonnenberg Time trends of ulcer mortality in Europe. , 2007, Gastroenterology.

[10]  A. Sonnenberg Time Trends of Ulcer Mortality in Non-European Countries , 2007, The American Journal of Gastroenterology.

[11]  A. Majeed,et al.  Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982–2002 , 2006, Alimentary pharmacology & therapeutics.

[12]  J. Hallas,et al.  Complicated and Uncomplicated Peptic Ulcers in a Danish County 1993–2002: A Population-Based Cohort Study , 2006, The American Journal of Gastroenterology.

[13]  V. Wong,et al.  Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. , 2008, Gastroenterology.

[14]  L. Strate Lower GI bleeding: epidemiology and diagnosis. , 2005, Gastroenterology clinics of North America.

[15]  E. Rauws,et al.  Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  R. Knill-Jones,et al.  Upper gastrointestinal haemorrhage associated with low‐dose aspirin and anti‐thrombotic drugs – a 6‐year analysis and comparison with non‐steroidal anti‐inflammatory drugs , 2005, Alimentary pharmacology & therapeutics.

[17]  C. Ohmann,et al.  Time-trends in the epidemiology of peptic ulcer bleeding , 2005, Scandinavian journal of gastroenterology.

[18]  K. D. Bardhan,et al.  Admission rates for peptic ulcer in the trent region, UK, 1972--2000. changing pattern, a changing disease? , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  F. Chang,et al.  Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trial , 2004, Hepatology.

[20]  D. Shindler Aortic stenosis and gastrointestinal bleeding. , 2004, Archives of internal medicine.

[21]  G. D’Amico,et al.  Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators , 2003, Hepatology.

[22]  J. Sung,et al.  Dieulafoy's lesion. , 2003, Gastrointestinal endoscopy.

[23]  J. Reitsma,et al.  Acute upper GI bleeding: did anything change? , 2003, American Journal of Gastroenterology.

[24]  A. Majeed,et al.  Peptic ulceration in general practice in England and Wales 1994–98: period prevalence and drug management , 2002, Alimentary pharmacology & therapeutics.

[25]  A. Hart,et al.  Epidemiology of duodenal ulcer perforation: a study on hospital admissions in Norfolk, United Kingdom. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  E. Kivilaakso,et al.  Current Features of Peptic Ulcer Disease in Finland: Incidence of Surgery, Hospital Admissions and Mortality for the Disease During the Past Twenty-five Years , 2002, Scandinavian journal of gastroenterology.

[27]  M. Langman,et al.  Ulcer complications associated with anti‐inflammatory drug use. What is the extent of the disease burden? , 2001, Pharmacoepidemiology and drug safety.

[28]  J. Everhart Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.

[29]  J. Rodés,et al.  Prognostic value of early measurements of portal pressure in acute variceal bleeding. , 1999, Gastroenterology.

[30]  I. Gotsman,et al.  Liver‐associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model , 1999, Hepatology.

[31]  G. Zuckerman,et al.  Acute lower intestinal bleeding. Part II: etiology, therapy, and outcomes. , 1999, Gastrointestinal endoscopy.

[32]  A. Burroughs,et al.  Bacterial infection in the pathogenesis of variceal bleeding , 1999, The Lancet.

[33]  K. D. Bardhan,et al.  The outcome of bleeding duodenal ulcer in the era of H2 receptor antagonist therapy. , 1998, QJM : monthly journal of the Association of Physicians.

[34]  Jill P. Pell,et al.  Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study , 1997, BMJ.

[35]  C. Wilcox,et al.  A prospective characterization of upper gastrointestinal hemorrhage presenting with hematochezia. , 1997, The American journal of gastroenterology.

[36]  D. Jensen,et al.  Management of upper gastrointestinal bleeding in the patient with chronic liver disease. , 1996, The Medical clinics of North America.

[37]  T. Rockall,et al.  Variation in outcome after acute upper gastrointestinal haemorrhage , 1995, The Lancet.

[38]  G. Longstreth Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. , 1995, The American journal of gastroenterology.

[39]  J. Vinel,et al.  Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. , 1995, Gastroenterology.

[40]  D. Ransohoff,et al.  Aortic stenosis, idiopathic gastrointestinal bleeding, and angiodysplasia: is there an association? A methodologic critique of the literature. , 1988, Gastroenterology.

[41]  P. Arcidiacono,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study , 1988 .

[42]  S. Kitano,et al.  Prediction of variceal hemorrhage by esophageal endoscopy. , 1981, Gastrointestinal endoscopy.

[43]  J. Persing,et al.  The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. , 1981, Gastrointestinal endoscopy.

[44]  D. Graham,et al.  The course of patients after variceal hemorrhage , 1981 .

[45]  H. Watts,et al.  Mallory-Weiss syndrome. A reappraisal. , 1974, JAMA.